PJSC Farmak (Kyiv), among top three leaders of the pharmaceutical sector of Ukraine, in 2018 plans to increase the exports share to 33%.
The company told Interfax-Ukraine that in H1 2018 Farmak’s exports grew by 13% year-over-year, in particular, thanks to supplies to Uzbekistan (a rise by 20%), Belarus (by 124%), Kazakhstan (by 13%) and Kyrgyzstan (by 16%).
Sales of products to Russia remained at the level of 2017.
“We want to increase the export potential of the company by retaining the leading positions in Ukraine. It would lead to an increase in production, creation of new jobs, an increase in the amount of taxes paid. For Farmak, the markets of the European Union and Asia remain a priority,” Farmak Executive Director Volodymyr Kostiuk said.
In general, according to him, in 2017, Farmak exported products for $70 million. In 2017, Poland, Uzbekistan and Russia dominated the structure of foreign sales. In particular, sales to Poland accounted for 28.3% of total exports, Uzbekistan – 20.9% and Russia – 16.7%.
In 2017, the share of Farmak’s sales in foreign markets was 31%.
Farmak is a member of the Association Manufacturers of Medications of Ukraine (AMMU).
EXPORTS, FARMAK, PHARMACEUTICAL COMPANY
